SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
What is the latest Net Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-348 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹276 Cr |
How is Net Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-348 Cr | Negative | |
| Mar2024 | ₹4.33 Cr | -98.43 | |
| Mar2023 | ₹276 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹8,586.3 Cr | 1.1% | 28.6% | 74.3% | Stock Analytics | |
| SAGILITY | ₹19,895.7 Cr | 4.7% | 5.9% | -3.9% | Stock Analytics | |
| PRIME FOCUS | ₹19,854.9 Cr | 9.3% | 12.5% | 52.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,968.2 Cr | -2.4% | -7.6% | -35.2% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,991.6 Cr | -2.6% | -3.5% | -8.2% | Stock Analytics | |
| INDEGENE | ₹12,277.5 Cr | 3.1% | -1.7% | -12.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 1.1% |
28.6% |
74.3% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses